City

Clinical trials near Kunming, China

Active studies with a listed research site in Kunming, China.

10active studies

5recruiting now

5countries represented

138largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Sleep Apnea, Obstructive, ObesityCondition

Eloralintide, PlaceboTreatment

Australia, Brazil115 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07369011See eligibility →

Recruiting nowPhase 1

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)Condition

MWN105 1, MWN105 2Treatment

China1 locations

Shanghai Minwei Biotechnology Co., LtdSponsor

Updated 2026-09-08 · NCT07803809See eligibility →

Recruiting nowNot applicable

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

ObesityCondition

BS-GLP1RA group, BS groupTreatment

China7 locations

China-Japan Friendship HospitalSponsor

Updated 2026-07-29 · NCT07732738See eligibility →

Recruiting nowPhase 1

A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants

Overweight or ObesityCondition

BGM1812, PlaceboTreatment

China1 locations

BrightGene Bio-Medical Technology Co., Ltd.Sponsor

Updated 2025-12-19 · NCT07294235See eligibility →

Recruiting nowPhase 1

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

Healthy, Non-diabetic Overweight or ObeseCondition

BGM0504 tablets, Placebo tabletsTreatment

China1 locations

BrightGene Bio-Medical Technology Co., Ltd.Sponsor

Updated 2025-11-20 · NCT07239973See eligibility →

Opening soonPhase 1

Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants

Overweight , ObesityCondition

MWN110, MWN110Treatment

China1 locations

Shanghai Minwei Biotechnology Co., LtdSponsor

Updated 2026-08-24 · NCT07779980See eligibility →

Opening soonNot applicable

Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity

Severe ObesityCondition

Sleeve gastrectomy plus early mazdutide initiation, Sleeve gastrectomy followed with early mazdutide placebo initationTreatment

China14 locations

Beijing Friendship HospitalSponsor

Updated 2025-08-21 · NCT07135141See eligibility →

Active, not recruitingPhase 3

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Obesity, OverweightCondition

Orforglipron, PlaceboTreatment

Brazil, China138 locations

Eli Lilly and CompanySponsor

Updated 2026-08-14 · NCT05869903See eligibility →

Active, not recruitingPhase 2, Phase 3

The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)

Obesity and OverweightCondition

Phase IIb：Efsubaglutide Alfa 5 mg QW, Phase IIb：Efsubaglutide Alfa 10 mg QWTreatment

China41 locations

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Sponsor

Updated 2026-01-30 · NCT06921486See eligibility →

Active, not recruitingNot applicable

A Clinical Study of the Effects of Environmental Pollution on Obesity

Obesity and OverweightCondition

ObesityTreatment

China3 locations

Dong PengSponsor

Updated 2024-11-01 · NCT06670703See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Kunming, China

Current studies

Related cities